Which innovative marketing strategy did Broad Institute and UC Berkeley employ during their CRISPR patent dispute that changed how scientific tools are commercialized?
Gene editing technology has transformed not just science, but also how biotech companies market breakthrough innovations. This poll tests your knowledge about the marketing and branding strategies behind one of the most significant scientific breakthroughs of the 21st century. How well do you understand the intersection of cutting-edge science and marketing strategy?
This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.
- They created non-exclusive licensing programs allowing widespread research use while maintaining commercial rights, revolutionizing scientific tool accessibility
- They established a joint marketing venture called 'CRISPR Collaborative' that unified their branding while maintaining separate intellectual property claims
- They launched competing subscription services where researchers could pay monthly fees for updated CRISPR techniques and reagents
- They created exclusive regional marketing territories, with Broad handling North American promotion and Berkeley managing European and Asian markets
Powered by AIPolls.Net — AI-powered real-time polling platform.